| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5833942 | International Immunopharmacology | 2012 | 6 Pages |
It is well known that the inflammatory cytokines play important roles in osteoarthritis (OA). In the present study, we investigated the anti-inflammatory properties of morin in chondrocytes. The nitric oxide (NO) production was determined by Griess method, the prostaglandin E2 (PGE2) production was detected by Enzyme-linked immunosorbent assay (ELISA). The expression of inducible NO synthase (iNOS) and cyclooxygenase (COX)-2 were investigated by quantitative real-time PCR and western blot. In addition, western blotting and immunofluorescence staining were performed to investigate the protein level of inhibitor of nuclear factor-κB (IκB-α) and the translocation of nuclear factor kappa B (NF-κB). For the in vivo study, morin was administered by intra-articular injection in rats, and the gene expression of iNOS and COX-2 was assessed. We showed that morin inhibited the production of NO and PGE2 as well as the expression of iNOS and COX-2 in interleukin-1-beta (IL-1β)-induced chondrocytes. In addition, morin suppressed the degradation of IκB-α as well as the translocation of NF-κB. In vivo study, morin exerted anti-inflammatory properties in an IL-1β-induced rat OA model. Our data suggest that morin possess potential value in the treatment of OA.
⺠Morin inhibited the production of NO and PGE2 as well as the expression of iNOS and COX-2 in interleukin-1-beta (IL-1β)-induced chondrocytes. ⺠Morin suppressed the degradation of IκB-α as well as the translocation of NF-κB. ⺠Morin exerted anti-inflammatory properties in an IL-1β-induced rat OA model.
